Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Pulmonary Artery Hypertension
NCT07907757Phase 2Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Oct 2026
- Primary completion
- Jan 2027
01
Overview
Phase 2, randomised, open-label trial of colchicine in pulmonary arterial hypertension (PAH) (2 arms), sponsored by Ain Shams University. Primary endpoint: World Health Organization Functional Class at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT07907757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07907757.